H Huber

655 total citations
7 papers, 48 citations indexed

About

H Huber is a scholar working on Molecular Biology, Dermatology and Oncology. According to data from OpenAlex, H Huber has authored 7 papers receiving a total of 48 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Dermatology and 2 papers in Oncology. Recurrent topics in H Huber's work include Neuroendocrine Tumor Research Advances (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Chemical Safety and Risk Management (1 paper). H Huber is often cited by papers focused on Neuroendocrine Tumor Research Advances (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and Chemical Safety and Risk Management (1 paper). H Huber collaborates with scholars based in Austria and Germany. H Huber's co-authors include H. Kaufmann, Johannes Drach, J Ackermann, R. Heinz, Niklas Zojer, S. Schreiber, Josef Auböck, Gerold Schuler, Xaver Baur and Elisabeth Müller‐Holzner and has published in prestigious journals such as Journal of the American Medical Association, Annals of Hematology and DMW - Deutsche Medizinische Wochenschrift.

In The Last Decade

H Huber

4 papers receiving 47 citations

Peers

H Huber
Comparison fields: 5 of 18
  • Hematology 30
  • Genetics 25
  • Pathology and Forensic Medicine 17
  • Molecular Biology 16
  • Oncology 8
Replace Caterina Consarino with:
Caterina Consarino Italy
Srivalli Gopaluni United States
Alexandra Christodoulou United States
Shaneice Mitchell United States
Jan Duerig Germany
Oana Stanca Romania
T. Karrison United States
Christopher R. Hake United States
Neus Ruiz‐Xivillé Spain
Sonia Fox United Kingdom
Caterina Consarino Italy View profile →
Citations per field, relative to H Huber
H Huber · 1×
Citations per year, relative to H Huber
H Huber · 1×

Countries citing papers authored by H Huber

Since Specialization
Citations

This map shows the geographic impact of H Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Huber more than expected).

Fields of papers citing papers by H Huber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Huber. The network helps show where H Huber may publish in the future.

Co-authorship network of co-authors of H Huber

This figure shows the co-authorship network connecting the top 25 collaborators of H Huber. A scholar is included among the top collaborators of H Huber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Huber. H Huber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
# Work Indexed citations
1 0
2 0
3 13
4 28
5
[Bleomycin-induced linear hyperpigmentation].
3
6 1
7
[Clinical management of polypi of the uterine mucosa].
3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026